Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 24 | ALVR AlloVir | Common Stock | Grant | Acquire A | No | No | 0 | 35,000 | 0.00 | 70,000 |
3 Jun 24 | CABA Cabaletta Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 10.01 | 22,000 | 220.22 k | 22,000 |
21 May 24 | FDMT 4D Molecular Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.15 | 22,500 | 565.88 k | 22,500 |
31 Jan 24 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 241,977 |
19 Oct 23 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 28,300 | 0.00 | 41,977 |
19 Oct 23 | GMDAQ Gamida Cell | Share Option Ordinary Shares | Grant | Acquire A | No | No | 1.59 | 56,600 | 89.99 k | 56,600 |